Apr 21, 2025 | Biosimilars, Cost Savings, Drug costs, Rx Costs, Savings, Stelara
Earlier this month, MedBen Rx clients and their brokers were emailed about an opportunity to receive preferred pricing for the biosimilar for the anti-inflammatory medication Stelara. Depending on the dosage, this biosimilar can reduce the cost of the medication by...
Oct 15, 2024 | Benefits preservation, Biosimilars, Cost Savings, Drug costs, High-cost claims, Rx Costs, Specialty Drugs
Specialty drugs continue to drive up pharmacy costs, accounting for over 50% of total drug spend for many self-funded health plans, despite being used by a small percentage of patients. But pharmaceutical and administrative solutions are available to help reduce that...
Sep 3, 2024 | Biosimilars, Cost Savings, Drug costs, GLP-1s, Humira, Mounjaro, Ozempic, Rx Costs, Savings, Trulicity, Wegovy
Humira continued to be the costliest prescription drug for self-funded health plans in 2023 by a comfortable margin, according to a recent Milliman commercial drug trends review. Used to treat a variety of conditions from Crohn’s to rheumatoid arthritis and psoriatic...
Aug 5, 2024 | Biosimilars, Food and Drug Administration (FDA), Humalog, Humira, Opinions
From a STAT opinion piece by Juliana M. Reed, executive director of the Biosimilars Forum: “Biologic medicines are some of the most important drugs in the world. They are also among the most expensive. Biosimilars are FDA-approved treatments that are similar to...
Jul 5, 2024 | Biosimilars, Cost Savings, Humira, MedBen Rx, News, Rx Costs, Savings
The Food and Drug Administration is considering a change to its biosimilar policy that would greatly speed up their approval process – which, if enacted, would be a big win for MedBen Rx clients who are already reducing their prescription drug spend through...
Apr 30, 2024 | Alternative Reimbursement Strategies, Biosimilars, Brian Fargus, Brooke Hupp, Caroline Fraker, Fair market reimbursement, Kurt Harden, MedBen Rx, MedBen University, Mental health parity, Municipalities, Nutrigenomics, Pharmacogenomics, Roundtables
At the 18th Annual MedBen University Municipality & Public Employer Roundtable on April 24, clients were shown how MedBen’s self-funding solutions are lowering medical and pharmacy spend while promoting healthier workplaces. Attendees were also introduced to...
